CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,416 | -50.5% | 15,474 | -17.6% | 0.00% | -100.0% |
| Q1 2023 | $172,680 | -84.3% | 18,790 | -82.5% | 0.00% | -85.0% |
| Q4 2022 | $1,096,993 | +412.6% | 107,443 | +638.7% | 0.02% | +400.0% |
| Q3 2022 | $214,000 | -79.7% | 14,544 | -85.1% | 0.00% | -85.7% |
| Q1 2022 | $1,055,000 | -1.8% | 97,852 | +48.7% | 0.03% | -15.2% |
| Q4 2021 | $1,074,000 | +145.8% | 65,820 | +222.6% | 0.03% | +175.0% |
| Q3 2021 | $437,000 | – | 20,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |